Advances in the Management of Patients With Urothelial Carcinomas of the Bladder
Presented by Amishi Shah, MD, and Emily Lemke, DNP, AGPCNP-BC, AOCNP®
The University of Texas MD Anderson Cancer Center
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2018;9(3):316–320 |
© 2018 Harborside™
For more than 30 years, there were no new treatments in bladder cancer. Then, in 2016, there were five drug approvals. JADPRO Live presenters delved into recent advancements and opportunities for improving outcomes for patients with bladder cancer.
For access to the full length article, please sign in